We are live on ! Find out more
PL

Parkwood LLC Portfolio holdings

AUM $1.4B
1-Year Est. Return 33.21%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+33.21%
3 Year Est. Return
+120.13%
5 Year Est. Return
+126.38%
10 Year Est. Return
+485.1%
AUM
$1.1B
AUM Growth
-$17.3M
Cap. Flow
-$85M
Cap. Flow %
-7.74%
Top 10 Hldgs %
37.76%
Holding
104
New
19
Increased
23
Reduced
23
Closed
18

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$29M
2
NET icon
Cloudflare
NET
+$17.9M
3
SHOP icon
Shopify
SHOP
+$16.1M
4
NVDA icon
NVIDIA
NVDA
+$13.6M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.27%
2 Technology 22.71%
3 Financials 11.51%
4 Consumer Discretionary 9.93%
5 Communication Services 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
101
Visa
V
$691B
-23,884
Closed -$8.48M
XBI icon
102
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.7B
-4,600
Closed -$6.82M
SHPW
103
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$0 ﹤0.01%
+159,657
New
RAL
104
Ralliant Corp
RAL
$7.45B
-42,774
Closed -$2.07M

Similar funds

Parkwood LLC's Q3 2025 Portfolio in Review

As of Q3 2025, Parkwood LLC held 104 positions worth $1.1B, down 1.5% from $1.12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Parkwood LLC withdrew a net $85M in Q3 2025, closing 18 positions and reducing 23 holdings. Its most notable exit was AstraZeneca, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Parkwood LLC opened a new position in Axon Enterprise worth $27.4M.

  • Parkwood LLC's largest Q3 2025 buy was Axon Enterprise: 38,250 shares worth $27.4M.
  • Parkwood LLC added most to Amazon in Q3 2025, an estimated $12.7M increase.
  • Parkwood LLC's biggest Q3 2025 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $29.4M.
  • Parkwood LLC fully exited AstraZeneca in Q3 2025, selling an estimated $15.3M.
  • Parkwood LLC's ten largest holdings make up 38% of its $1.1B portfolio in Q3 2025.
  • Parkwood LLC opened 19 new positions and closed 18 in Q3 2025.
  • Parkwood LLC's portfolio value fell 1.5% quarter-over-quarter to $1.1B.

Based on Parkwood LLC's 13F filing for Q3 2025, filed 14 Nov 2025.